Abstract | OBJECTIVE: We determined the association between various clinical parameters and significant liver injury in both hepatitis B e antigen ( HBeAg)-positive and HBeAg-negative patients. METHODS: From 1994 to 2008, liver biopsy was performed on 319 treatment-naïve CHB patients. Histologic assessment was based on the Knodell histologic activity index for necroinflammation and the Ishak fibrosis staging for fibrosis. RESULTS: 211 HBeAg-positive and 108 HBeAg-negative patients were recruited, with a median age of 31 and 46 years respectively. 9 out of 40 (22.5%) HBeAg-positive patients with normal ALT had significant histologic abnormalities (necroinflammation grading ≥ 7 or fibrosis score ≥ 3). There was a significant difference in fibrosis scores among HBeAg-positive patients with an ALT level within the Prati criteria (30 U/L for men, 19 U/L for women) and patients with a normal ALT but exceeding the Prati criteria (p = 0.024). Age, aspartate aminotransferase and platelet count were independent predictors of significant fibrosis in HBeAg-positive patients with an elevated ALT by multivariate analysis (p = 0.007, 0.047 and 0.045 respectively). HBV DNA and platelet count were predictors of significant fibrosis in HBeAg-negative disease (p = 0.020 and 0.015 respectively). An elevated ALT was not predictive of significant fibrosis for HBeAg-positive (p = 0.345) and -negative (p = 0.544) disease. There was no significant difference in fibrosis staging among ALT 1-2 × upper limit of normal (ULN) and > × 2 ULN for both HBeAg-positive (p = 0.098) and -negative (p = 0.838) disease. CONCLUSION: An elevated ALT does not accurately predict significant liver injury. Decisions on commencing antiviral therapy should not be heavily based on a particular ALT threshold.
|
Authors | Wai-Kay Seto, Ching-Lung Lai, Philip P C Ip, James Fung, Danny Ka-Ho Wong, John Chi-Hang Yuen, Ivan Fan-Ngai Hung, Man-Fung Yuen |
Journal | PloS one
(PLoS One)
Vol. 7
Issue 2
Pg. e32622
( 2012)
ISSN: 1932-6203 [Electronic] United States |
PMID | 22389715
(Publication Type: Journal Article)
|
Chemical References |
- Hepatitis B e Antigens
- Alanine Transaminase
|
Topics |
- Adolescent
- Adult
- Alanine Transaminase
(metabolism)
- Female
- Hepatitis B e Antigens
(metabolism)
- Hepatitis B, Chronic
(enzymology, pathology)
- Humans
- Liver Cirrhosis
(enzymology, pathology)
- Male
- Middle Aged
- Young Adult
|